Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: The aim of this study was to examine the potential added value of including neuropsychiatric symptoms (NPS) in machine learning (ML) models, along with demographic features and Alzheimer's disease (AD) biomarkers, to predict decline or non-decline in global and domain-specific cognitive scores among community-dwelling older adults.
BACKGROUND: Mild cognitive impairment (MCI) is recognized as a condition that may increase the risk of developing Alzheimer's disease (AD). Understanding the neural correlates of MCI is crucial for elucidating its pathophysiology and developing effective interventions. Electroencephalogram (EEG) microstates, reflecting brain activity changes, have shown promise in MCI research. However, current ap...
BACKGROUND: Many members of Black American communities, faced with the high prevalence of Alzheimer disease and related dementias (ADRD) within their ...
BACKGROUND: Alzheimer's disease (AD) is a complex neurodegenerative disorder with a largely unexplored epigenetic landscape.
Emerging researchindicates that the degenerative biomarkers associated with Alzheimer's disease (AD) exhibit a non-random distribution within the cere...
Predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is critical for early intervention. Towards this end, vari...
BACKGROUND: Polygenic risk score (PRS) prediction is widely used to assess the risk of diagnosis and progression of many diseases. Routinely, the weig...
Alzheimer's disease (AD) is a prototypical neurodegenerative disorder, predominantly affecting individuals in the presenile and elderly populations, w...
Alzheimer's disease (AD), a progressive neurodegenerative condition, notably impacts cognitive functions and daily activity. One method of detecting d...
BACKGROUND: As a clinical precursor to Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI) bears a considerably heightened risk of tra...
PURPOSE: Xixin Decoction (XXD) is a classical formula that has been used to effectively treat dementia for over 300 years. Modern clinical studies hav...
The rising incidence of Alzheimer's disease (AD) poses significant challenges to traditional diagnostic methods, which primarily rely on neuropsycholo...
BACKGROUND: The hippocampus plays a crucial role in memory and is one of the first structures affected by Alzheimer's disease. Postmortem MRI offers a...
The diagnosis of neurological diseases can be expensive, invasive, and inaccurate, as it is often difficult to distinguish between different types of ...
The interconnection between brain regions in neurological disease encodes vital information for the advancement of biomarkers and diagnostics. Althoug...
The linear mixed-effects model is commonly utilized to interpret longitudinal data, characterizing both the global longitudinal trajectory across all ...
Early diagnosis of neurodegenerative diseases, such as Alzheimer's disease, improves treatment and care outcomes for patients. Early signs of cognitiv...
BACKGROUND: Protein abundance levels, sensitive to both physiological changes and external interventions, are useful for assessing the Alzheimer's dis...
DNA methylation (DNAm) is essential for brain development and function and potentially mediates the effects of genetic risk variants underlying brain ...
The patch clamp technique is a fundamental tool for investigating ion channel dynamics and electrophysiological properties. This study proposes the fi...